VIDEO: Phase 2 Study of Zanidatamab + Chemotherapy in First-line HER2-expressing Gastroesophageal Adenocarcinoma (GEA) (Presented by: Geoffrey Ku, MD; European Society of Medical Oncology Annual Congress, September 16, 2021)
